Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannan Henry

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Psychopharmacology (Oxford, England)|December 14, 2022
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adultsDavid Matuskey, Jean-Dominique Gallezot, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Kinetic Modeling and Test-Retest Reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>C-FEKAP, Novel Agonist Radiotracers for PET Imaging of the κ-Opioid Receptor in HumansMika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2014
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivorsRobert H Pietrzak, Yiyun Huang, Stefani Corsi-Travali, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2020
Retraction Note: Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivorsRobert H Pietrzak, Yiyun Huang, Stefani Corsi-Travali, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 4, 2014
Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humansMika Naganawa, Ming-Qiang Zheng, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
First-in-Human Evaluation of <sup>18</sup>F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2AMika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Psychiatry Research. Neuroimaging|November 25, 2019
In vivo 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [<sup>11</sup>C]GSK215083 PETRajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2012
Age effects on serotonin receptor 1B as assessed by PETDavid Matuskey, Brian Pittman, Beata Planeta-Wilson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 10, 2017
Kinetic evaluation and test-retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humansSjoerd J Finnema, Nabeel B Nabulsi, Joël Mercier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2021
Assessment of test-retest reproducibility of [<sup>18</sup>F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2ASongye Li, Mika Naganawa, Richard Pracitto, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Psychopharmacology (Oxford, England)|December 14, 2022
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adultsDavid Matuskey, Jean-Dominique Gallezot, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Kinetic Modeling and Test-Retest Reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>C-FEKAP, Novel Agonist Radiotracers for PET Imaging of the κ-Opioid Receptor in HumansMika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2014
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivorsRobert H Pietrzak, Yiyun Huang, Stefani Corsi-Travali, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2020
Retraction Note: Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivorsRobert H Pietrzak, Yiyun Huang, Stefani Corsi-Travali, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 4, 2014
Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humansMika Naganawa, Ming-Qiang Zheng, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
First-in-Human Evaluation of <sup>18</sup>F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2AMika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Psychiatry Research. Neuroimaging|November 25, 2019
In vivo 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [<sup>11</sup>C]GSK215083 PETRajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2012
Age effects on serotonin receptor 1B as assessed by PETDavid Matuskey, Brian Pittman, Beata Planeta-Wilson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 10, 2017
Kinetic evaluation and test-retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humansSjoerd J Finnema, Nabeel B Nabulsi, Joël Mercier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2021
Assessment of test-retest reproducibility of [<sup>18</sup>F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2ASongye Li, Mika Naganawa, Richard Pracitto, et al.
Pageof 5